Holen Sie sich die Stockscreener-App
4.95
2.06%
0.10
Finanzdaten der Lexeo Therapeutics Inc-Aktie (LXEO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
9.22%
30.69
|
33.80 | 27.38 | 31.54 | 23.55 |
| Depreciation and Amortization |
3.33%
0.062
|
0.06 | 0.075 | 0.083 | 0.077 |
| Operating Income/Loss |
9.22%
-30.69
|
-33.80 | -27.38 | -31.54 | -23.55 |
| Nonoperating Income/Loss |
299.04%
4.585
|
1.149 | 1.458 | 2.054 | 2.312 |
| Income/Loss From Continuing Operations Before Tax |
20.07%
-26.10
|
-32.66 | -25.92 | -29.49 | -21.24 |
| Income/Loss From Continuing Operations After Tax |
20.07%
-26.10
|
-32.66 | -25.92 | -29.49 | -21.24 |
|
Net Income/Loss
|
20.07%
-26.10
|
-32.66 | -25.92 | -29.49 | -21.24 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
31.59%
43.57
|
33.11 | 0.4327 | 33.06 | 33.00 |
| Diluted Average Shares |
31.59%
43.57
|
33.11 | 0.4327 | 33.06 | 33.00 |
| Basic Earnings Per Share |
39.39%
-0.60
|
-0.99 | -0.78 | -0.89 | -0.64 |
| Diluted Earnings Per Share |
39.39%
-0.60
|
-0.99 | -0.78 | -0.89 | -0.64 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.53%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):